VXUS: Vanguard Total International Stock ETF returns, drawdowns and risk
Funds on developed markets outside the United States: Europe, Japan, Australia, Canada.
Data updated October 2026
VXUS · US exchange · USDCategory: International developed markets ETFsData from January 2011
From January 2011 to October 2026 VXUS returned 6.5% a year on average with dividends reinvested, in US dollars: $10,000 invested at the start grew to $26,930.
Its deepest fall was 36.0%, from January 2018 to March 2020, and it took about 34 months to get back to the previous high. Annual volatility was 17.7%; at the last close it was 5.1% below its high.
Against SPY (SPDR S&P 500 ETF Trust), over the 189 months both have data, the correlation of monthly returns was 0.83: they usually moved together. Beta was 0.89. In months when SPY rose, VXUS moved 78% as much on average; in months when SPY fell, 107% as much.
Key figures
- Annual return (CAGR)
- +6.5%
- 1-year return
- +14.6%
- 5 years, a year
- +8.2%
- 10 years, a year
- +9.1%
- Annual volatility
- 17.7%
- Maximum drawdown
- −36.0%
- Sharpe ratio
- 0.36
- Worst year
- 2022: −16.1%
Trailing returns
| Period | VXUS | SPY |
|---|---|---|
| 1 year | +14.6% | +16.6% |
| 3 years, a year | +21.0% | +23.1% |
| 5 years, a year | +8.2% | +12.7% |
| 10 years, a year | +9.1% | +15.4% |
To the last close of October 2026. Periods longer than a year are annualised.
Growth of $10,000: VXUS vs SPY
Month-end values from February 2011, the first month both funds have data.
VXUS drawdowns
Percentage below the previous high, weekly.
Returns by calendar year
| Year | VXUS | SPY |
|---|---|---|
| 2026(partial) | +11.8% | +13.3% |
| 2025 | +32.4% | +17.7% |
| 2024 | +5.1% | +24.9% |
| 2023 | +15.9% | +26.2% |
| 2022 | −16.1% | −18.2% |
| 2021 | +9.0% | +28.7% |
| 2020 | +10.7% | +18.3% |
| 2019 | +21.8% | +31.2% |
| 2018 | −14.4% | −4.6% |
| 2017 | +27.5% | +21.7% |
| 2016 | +4.8% | +12.0% |
| 2015 | −4.2% | +1.2% |
| 2014 | −4.7% | +13.5% |
| 2013 | +14.6% | +32.3% |
| 2012 | +18.6% | +16.0% |
| 2011(partial) | −14.4% | — |
VXUS compared
How the figures are calculated
Total return in the fund’s trading currency, from end-of-day prices with dividends reinvested on the ex-date. The fund’s own ongoing charges are already reflected in its price; trading costs, taxes and currency conversion are not included. Past returns do not predict future returns.
Sharpe ratio uses the return of short-term government bills in the same currency as the risk-free rate. The growth chart uses month-end values; drawdowns and volatility use daily closes.
Questions
What is the average annual return of VXUS?
From January 2011 to October 2026 VXUS returned 6.5% a year on average (CAGR) with dividends reinvested, in USD. Over the last 5 years: +8.2% a year. Over the last 12 months: +14.6%.
What was the worst drawdown of VXUS?
36.0%, from January 2018 to March 2020; it took about 34 months from the previous high to get back to it.
How volatile is VXUS?
Annual volatility was 17.7% over the period. Its worst month was −16.3% and 58% of months were positive. Worst calendar year: 2022 (−16.1%).
How closely does VXUS follow SPY?
Over 189 months the correlation of monthly returns was 0.83, so they usually moved together, with a beta of 0.89.
Use VXUS in a free tool
Other International developed markets ETFs
- All International developed markets ETFsReturns and risk side by side
- VEA — Vanguard FTSE Developed Markets ETFCAGR +12.9%
- IEFA — iShares Core MSCI EAFE ETFCAGR +8.3%
- EFA — iShares MSCI EAFE ETFCAGR +5.1%
- IXUS — iShares Core MSCI Total International Stock ETFCAGR +7.7%
- SCZ — iShares MSCI EAFE Small-Cap ETFCAGR +5.4%
- VSS — Vanguard FTSE All-World ex-US Small-Cap ETFCAGR +10.8%
- EWJ — iShares MSCI Japan ETFCAGR +6.8%
- EWC — iShares MSCI Canada ETFCAGR +6.8%
- EWA — iShares MSCI Australia ETFCAGR +6.0%
Source: MarketStack end-of-day prices, total return with dividends reinvested. Figures are historical and descriptive; they are not forecasts and not investment advice. MEDGE Capital does not recommend buying or selling any instrument. Risk disclaimer.